Literature DB >> 21241804

Paediatric pharmacology: remember the excipients.

Valentina Fabiano, Chiara Mameli, Gian Vincenzo Zuccotti.   

Abstract

Excipients are largely used by pharmaceutical industry to guarantee preservation and stability and confer shape, volume and consistency to pharmaceutical preparations. They are particularly important in medicines intended for prescription in children since they often play a critical role in manufacturing of suitable paediatric formulations. It was generally believed that excipients were inert substances; on the contrary, it is actually well known that excipients are far from being inactive and much more interest is growing about safety issues associated with their extensive use by pharmaceutical industry in general, and for manufacturing of paediatric drugs in particular.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21241804     DOI: 10.1016/j.phrs.2011.01.006

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  25 in total

Review 1.  Formulations for children: problems and solutions.

Authors:  Hannah K Batchelor; John F Marriott
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

Review 2.  Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use.

Authors:  Maren Preis
Journal:  AAPS PharmSciTech       Date:  2015-03-05       Impact factor: 3.246

3.  Biopharmaceutical optimization in neglected diseases for paediatric patients by applying the provisional paediatric biopharmaceutical classification system.

Authors:  Jose Manuel Del Moral Sanchez; Isabel Gonzalez-Alvarez; Aaron Cerda-Revert; Marta Gonzalez-Alvarez; Andres Navarro-Ruiz; Gordon L Amidon; Marival Bermejo
Journal:  Br J Clin Pharmacol       Date:  2018-07-17       Impact factor: 4.335

4.  Toxic excipients in medications for neonates in Brazil.

Authors:  Alcidésio Souza; Djanilson Santos; Said Fonseca; Marina Medeiros; Lívia Batista; Mark Turner; Helena Coelho
Journal:  Eur J Pediatr       Date:  2014-02-06       Impact factor: 3.183

5.  Neonates need tailored drug formulations.

Authors:  Karel Allegaert
Journal:  World J Clin Pediatr       Date:  2013-02-08

6.  The use of ethanol in paediatric formulations in New Zealand.

Authors:  Darren Svirskis; Meiyen Toh; Sanyogita Ram
Journal:  Eur J Pediatr       Date:  2013-02-26       Impact factor: 3.183

Review 7.  Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use.

Authors:  Joël Schlatter; David Nguyen; Michèle Zamy; Sofiane Kabiche; Jean-Eudes Fontan; Salvatore Cisternino
Journal:  Eur Spine J       Date:  2017-11-18       Impact factor: 3.134

8.  Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions.

Authors:  Hudson C Polonini; Sharlene L Silva; Thalyta R de Almeida; Marcos Antônio F Brandão; Anderson O Ferreira
Journal:  Eur J Hosp Pharm       Date:  2016-03-24

9.  A retrospective and observational analysis of harmful excipients in medicines for hospitalised neonates in Latvia.

Authors:  Inese Sviestina; Dzintars Mozgis
Journal:  Eur J Hosp Pharm       Date:  2017-03-03

10.  Compatibility of proton pump inhibitors in a preservative-free suspending vehicle.

Authors:  Hudson C Polonini; Sharlene L Silva; Shirley Loures; Rachel Almy; Antoine Balland; Marcos Antônio F Brandão; Anderson O Ferreira
Journal:  Eur J Hosp Pharm       Date:  2016-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.